You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (2) |
Back to Search
Analysis on reasons for discontinuation of sglt2i in type 2 diabetes mellitus patients in taiwan
- At: Glasgow (Scotland) (2018)
- Type: Poster
- Poster code: POS-HPS-081
- By: LIN, Yi-Han (Chang Gung Memorial Hospital, Keelung, Taiwan, Department of Pharmacy)
- Co-author(s): Yi-Han Lin: Department of Pharmacy, Chang Gung Memorial Hospital, Keelung, Taiwan, Keelung city, Taiwan, Province of China
Shih-Chieh Shao: Department of Pharmacy, Chang Gung Memorial Hospital, Keelung, Taiwan, Keelung city, Taiwan, Province of China;School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan city, Taiwan, Province of China
Yuk-Ying Chan: Department of Pharmacy, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China
Hui-Yu Chen: Department of Pharmacy, Chang Gung Memorial Hospital, Keelung, Taiwan, Keelung city, Taiwan, Province of China - Abstract:
Background
Adherence on glucose co-transporter 2 inhibitors (SGLT2i) is the primary issue for type 2 diabetes mellitus (T2DM) patients in real-world settings. Understanding the reasons for discontinuations is crucial for successful strategies to improve treatment outcome.Methods
We conducted a cohort study and analyzed the data of three hospitals in .. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026